2914 Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended, 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Eye Institute, including 

consideration of personnel 

qualifications and performances, and 

the competence of individual 

investigators, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, National Eye Institute. 

Date: February 27–March 1, 2011. 

Time: 7 a.m. to 5 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, MD 

20892. 

Contact Person: Sheldon S. Miller, PhD, 

Scientific Director, National Institutes of 

Health, National Eye Institute, Bethesda, MD 

20892, (301) 451–6763. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nei.nih.gov, where an agenda and any 

additional information will be posted when 

available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Vision Research, 

National Institutes of Health, HHS) 

Dated: January 11, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–880 Filed 1–14–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; PSI Materials Repository Review. 

Date: February 11, 2011. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Room 

3AN18, Bethesda, MD 20892. (Telephone 

Conference Call.) 

Contact Person: Brian R. Pike, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN18K, Bethesda, 

MD 20892, 301–594–3907, 

pikbr@nigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: January 11, 2011. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–877 Filed 1–14–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Advisory Board, February 7, 2011, 6:30 

p.m. to February 9, 2011, 12 p.m., 

National Institutes of Health, Building 

31, 31 Center Drive, Bethesda, MD 

20892 which was published in the 

Federal Register on December 29, 2010, 

75 FR 82035. 

This notice is being amended to 

cancel the Subcommittee on Clinical 

Investigations meeting on February 7, 

2011 from 6:30 p.m. to 8 p.m. and to 

cancel the National Cancer Advisory 

Board Meeting on February 9, 2011 from 

9 a.m. to 12 p.m. The meeting will be 

open to the public on February 8, 2011 

from 9 a.m. to 3:15 p.m. and the closed 

session will be from 3:30 p.m. to 5 p.m. 

The meeting is partially closed to the 

public. 

Dated: January 11, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–872 Filed 1–14–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Oral Microbiology. 

Date: January 27–28, 2011. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting.) 

Contact Person: Baljit S. Moonga, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1777, moongabs@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Notices 2915 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Risk Prevention and Health 

Behavior. 

Date: February 2, 2011. 

Time: 10 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call.) 

Contact Person: Claire E. Gutkin, PhD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3106, 

MSC 7808, Bethesda, MD 20892, 301–594– 

3139, gutkincl@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Molecular 

Neuropharmacology and Signaling Study 

Section. 

Date: February 7–8, 2011. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Deborah L. Lewis, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4183, 

MSC 7850, Bethesda, MD 20892, 301–408– 

9129, lewisdeb@csr.nih.gov. 

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences Integrated Review Group; 

Skeletal Biology Development and Disease 

Study Section. 

Date: February 9–10, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Delfina, 530 West Pico 

Boulevard, Santa Monica, CA 90405. 

Contact Person: Priscilla B. Chen, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4104, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1787. chenp@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Cellular and Molecular 

Biology of Neurodegeneration Study Section. 

Date: February 9–10, 2011. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Monaco, 501 Geary Street, San 

Francisco, CA 94102. 

Contact Person: Laurent Taupenot, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4183, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1203. taupenol@csr.nih.gov. 

Name of Committee: Immunology 

Integrated Review Group; Innate Immunity 

and Inflammation Study Section. 

Date: February 10–11, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Guest Suites Santa 

Monica Hotel, 1707 Fourth Street, Santa 

Monica, CA 90401. 

Contact Person: Tina McIntyre, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4202, 

MSC 7812, Bethesda, MD 20892. 301–594– 

6375. mcintyrt@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group; 

Host Interactions with Bacterial Pathogens 

Study Section. 

Date: February 11, 2011. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marina del Rey Hotel, 13534 Bali 

Way, Marina del Rey, CA 90292. 

Contact Person: Fouad A El-Zaatari, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7808, Bethesda, MD 20892. (301) 435– 

1149. elzaataf@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR08–130: 

International Research in Infectious Diseases 

including AIDS (IRIDA). 

Date: February 11, 2011. 

Time: 1 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marina del Rey Hotel, 1354 Bali 

Way, Marina del Rey, CA 90292. 

Contact Person: Soheyla Saadi, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3211, 

MSC 7808, Bethesda, MD 20892. 301–435– 

0903. saadisoh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Collaborative: Cardiovascular Disease and 

Epidemiology. 

Date: February 11, 2011. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: J Scott Osborne, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4114, 

MSC 7816, Bethesda, MD 20892. (301) 435– 

1782. osbornes@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 11, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–871 Filed 1–14–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2010–0087] 

RIN 1601–ZA09 

Identification of Foreign Countries 

Whose Nationals Are Eligible To 

Participate in the H–2A and H–2B 

Nonimmigrant Worker Programs 

AGENCY: Office of the Secretary, DHS. 

ACTION: Notice. 

SUMMARY: Under Department of 

Homeland Security (DHS) regulations, 

U.S. Citizenship and Immigration 

Services (USCIS) may approve petitions 

for H–2A and H–2B nonimmigrant 

status only for nationals of countries 

that the Secretary of Homeland Security, 

with the concurrence of the Secretary of 

State, has designated by notice 

published in the Federal Register. That 

notice must be renewed each year. This 

notice announces that the Secretary of 

Homeland Security, in consultation 

with the Secretary of State, is 

identifying 53 countries whose 

nationals are eligible to participate in 

the H–2A and H–2B programs for the 

coming year. 

DATES: Effective Date: This notice is 

effective January 18, 2011, and shall be 

without effect at the end of one year 

after January 18, 2011. 

FOR FURTHER INFORMATION CONTACT: 

Alexander Hartman, Office of Policy, 

Department of Homeland Security, 

Washington, DC 20528, (202) 282–9820. 

SUPPLEMENTARY INFORMATION: 

Background: USCIS generally may 

approve H–2A and H–2B petitions only 

for nationals of countries that the 

Secretary of Homeland Security, with 

the concurrence of the Secretary of 

State, has designated as participating 

countries. Such designation must be 

published as a notice in the Federal 

Register and expires after one year. 

USCIS may, however, allow a national 

from a country not on the list to be 

named as a beneficiary of an H–2A or 

H–2B petition based on a determination 

that such participation is in the U.S. 

interest. See 8 CFR 214.2(h)(5)(i)(F) and 

8 CFR 214.2(h)(6)(i)(E). 

In designating countries to include on 

the list, the Secretary of Homeland 

Security, with the concurrence of the 

Secretary of State, will take into account 

factors including, but not limited to: (1) 

The country’s cooperation with respect 

to issuance of travel documents for 

citizens, subjects, nationals, and 

residents of that country who are subject 

to a final order of removal; (2) the 

number of final and unexecuted orders 

mstockstill on DSKH9S0YB1PROD with NOTICES